Carbapenem Market to Grow with a CAGR of 4.25% through 2029
Increasing incidence of drug-resistant infections and rising
global population and aging demographics are factors driving the Global
Carbapenem Market in the forecast period 2025-2029
According to TechSci Research report, “Carbapenem
Market – Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2029F”, the Global Carbapenem Market stood at USD 3.52 billion
in 2023 and is anticipated to grow with a CAGR of 4.25% through 2029. The global increase in multidrug-resistant (MDR) bacterial infections is a primary driver for the carbapenem market. MDR bacteria, such as those causing hospital-acquired infections, often resist multiple classes of antibiotics, making carbapenems essential as last-resort antibiotics. This surge in MDR infections elevates the demand for effective carbapenem antibiotics. Continuous advancements in pharmaceutical R&D are crucial for the carbapenem market. Innovations in drug formulation, delivery mechanisms, and the development of novel carbapenem compounds enhance the effectiveness and safety of these antibiotics. Investment in R&D by pharmaceutical companies leads to the introduction of new and improved carbapenem antibiotics, driving market growth.
Government initiatives and regulatory support significantly contribute to the market's expansion. Regulatory bodies like the FDA and EMA provide guidelines and fast-track approval processes for new antibiotics that address MDR infections. These supportive policies encourage pharmaceutical companies to invest in the development of carbapenem antibiotics, facilitating market growth. The rise in hospital admissions and surgical procedures globally increases the risk of hospital-acquired infections (HAIs), which often require treatment with carbapenems. As the number of surgeries and hospital stays continues to grow, so does the demand for effective antibiotics to manage potential post-surgical infections.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Carbapenem Market”
The trend towards personalized medicine is significantly impacting the carbapenem market. Advances in genomic research and diagnostic technologies allow healthcare providers to customize antibiotic treatments based on individual patient profiles and specific bacterial strains. This tailored approach reduces the overuse of broad-spectrum antibiotics and enhances the effectiveness of carbapenems, driving their demand. Also, there is a growing interest in developing combination therapies that incorporate carbapenems with other antibiotics or adjunctive agents. These combinations can overcome resistance mechanisms in bacteria, resulting in more effective treatments. Pharmaceutical companies are investing in research to identify synergistic drug combinations, thereby expanding the therapeutic applications of carbapenems. Strategic partnerships between pharmaceutical companies, biotechnology firms, and academic institutions are on the rise. These collaborations facilitate the sharing of resources, expertise, and technology, accelerating the development of new carbapenem formulations and broadening their market reach. Joint ventures and mergers further enhance global distribution networks, improving market penetration.
The Global Carbapenem Market is segmented into drug
class, application, distribution channel and company.
Based on distribution channel, the Hospital Pharmacies segment has
emerged as the predominant market leader. Hospital pharmacies are responsible
for procuring and dispensing antibiotics, including carbapenems. Their role in
ensuring the timely availability of these critical medications cannot be
overstated. Pharmacists work closely with healthcare professionals to manage
inventory, ensure proper storage, and facilitate prompt administration to
patients who need them the most. Hospitals are increasingly implementing antibiotic
stewardship programs to combat drug resistance. These programs aim to ensure
that antibiotics, including carbapenems, are used judiciously to prevent the
development of further resistance. Hospital pharmacists play a central role in
monitoring antibiotic use, optimizing dosing, and promoting responsible
prescribing.
The Asia Pacific region is experiencing rapid market
growth. The healthcare infrastructure in Asia Pacific is well-developed, with
advanced diagnostic tools and treatment facilities. This facilitates the
accurate diagnosis of antibiotic-resistant infections, creating a robust market
for carbapenems.
Major companies operating in Global Carbapenem Market
are:
- Menarini Group
- Pfizer Inc.
- Sun
Pharmaceutical Industries Ltd
- Lupin Limited
- Kopran Limited
- Aurobindo
Pharma Limited
- Daewoong
Pharmaceuticals Co., Ltd.
- Shenzhen
Haibin Pharmaceutical Co. Ltd.
- Merck &
Co., Inc.
- Venus Remedies Ltd
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Global carbapenem market is driven by a complex
interplay of factors, including the rising incidence of drug-resistant
infections, an expanding global population, advancements in healthcare
infrastructure, and ongoing research and development in the pharmaceutical
industry. To ensure the long-term efficacy of carbapenems and the sustainable
management of antibiotic resistance, it is essential for all stakeholders,
including healthcare professionals, regulators, and patients, to work
collaboratively”, said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Carbapenem Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Meropenem, Imipenem, Ertapenem), By Application (Urinary Tract Infections, Blood Stream Infections, Pneumonia, Intra-abdominal Infections, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Carbapenem Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Carbapenem Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com